128 related articles for article (PubMed ID: 31257464)
1. Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration.
Ma Q; Gao FF; He X; Li K; Gao Y; Xu XL; Jiang NH; Ding L; Song WJ; He YQ; Pan WT; Wei L; Zhang JW
Mol Med Rep; 2019 Aug; 20(2):1943-1951. PubMed ID: 31257464
[TBL] [Abstract][Full Text] [Related]
2. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin B2 attenuates kidney fibrosis via inhibiting the Hedgehog Pathway.
Ren D; Luo J; Li Y; Zhang J; Yang J; Liu J; Zhang X; Cheng N; Xin H
Phytomedicine; 2020 Feb; 67():153163. PubMed ID: 31901891
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin B2 Suppresses Inflammatory Responses Through IKK/IκBα/NF-κB Signaling Inactivation in LPS-Induced RAW 264.7 Macrophages.
Shin JS; Im HT; Lee KT
Inflammation; 2019 Feb; 42(1):342-353. PubMed ID: 30251218
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.
Su K; Tian Y; Wang J; Shi W; Luo D; Liu J; Tong Z; Wu J; Zhang J; Wei L
DNA Cell Biol; 2012 Jun; 31(6):1078-87. PubMed ID: 22320863
[TBL] [Abstract][Full Text] [Related]
6. Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling.
You M; Fu J; Lv X; Wang L; Wang H; Li R
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37232376
[TBL] [Abstract][Full Text] [Related]
7. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Wang L; Shi H; Zhang X; Zhang X; Liu Y; Kang W; Shi X; Wang T
Oncol Rep; 2019 Jan; 41(1):427-436. PubMed ID: 30365149
[TBL] [Abstract][Full Text] [Related]
8. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters.
Zhao Y; Feng L; Liu L; Zhao R
Life Sci; 2019 Aug; 231():116557. PubMed ID: 31194994
[TBL] [Abstract][Full Text] [Related]
9. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
[TBL] [Abstract][Full Text] [Related]
10. ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
Zhang H; Cui X; Cao A; Li X; Li L
Gene; 2020 Apr; 734():144396. PubMed ID: 31987909
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
12. CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer.
Hu PC; Li K; Tian YH; Pan WT; Wang Y; Xu XL; He YQ; Gao Y; Wei L; Zhang JW
Int J Biol Sci; 2019; 15(12):2733-2749. PubMed ID: 31754343
[TBL] [Abstract][Full Text] [Related]
13. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
14. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
15. Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Lee BH; Kim DS; Song HJ; Jang BH; Shin YC; Ko SG
Oncol Rep; 2017 Aug; 38(2):715-724. PubMed ID: 28656316
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive indirect competitive enzyme-linked immunosorbent assay based on a monoclonal antibody against saikosaponin b2 for quality control of Kampo medicines containing Bupleuri radix.
Ochi A; Fujii S; Ohta T; Uto T; Nuntawong P; Tanaka H; Morimoto S; Sakamoto S
J Nat Med; 2024 Jan; 78(1):160-168. PubMed ID: 37804411
[TBL] [Abstract][Full Text] [Related]
17. Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.
Ali M; Heyob K; Jacob NK; Rogers LK
Mol Cancer Ther; 2016 Sep; 15(9):2220-31. PubMed ID: 27496138
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
[TBL] [Abstract][Full Text] [Related]
19. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
20. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
